CanSino Biologics Statistics
Total Valuation
HKG:6185 has a market cap or net worth of HKD 13.81 billion. The enterprise value is 12.29 billion.
| Market Cap | 13.81B |
| Enterprise Value | 12.29B |
Important Dates
The last earnings date was Thursday, March 5, 2026.
| Earnings Date | Mar 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
HKG:6185 has 247.04 million shares outstanding. The number of shares has increased by 2.32% in one year.
| Current Share Class | 132.67M |
| Shares Outstanding | 247.04M |
| Shares Change (YoY) | +2.32% |
| Shares Change (QoQ) | +59.67% |
| Owned by Insiders (%) | 31.39% |
| Owned by Institutions (%) | 7.08% |
| Float | 159.11M |
Valuation Ratios
The trailing PE ratio is 277.27 and the forward PE ratio is 21.15.
| PE Ratio | 277.27 |
| Forward PE | 21.15 |
| PS Ratio | 11.62 |
| PB Ratio | 2.52 |
| P/TBV Ratio | 2.62 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 396.36 |
| EV / Sales | 10.35 |
| EV / EBITDA | 52.77 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.29 |
| Debt / EBITDA | 6.81 |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 0.57% and return on invested capital (ROIC) is 0.67%.
| Return on Equity (ROE) | 0.57% |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 0.67% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 10.35% |
| Revenue Per Employee | 1.08M |
| Profits Per Employee | 28,070 |
| Employee Count | 1,115 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -6.83M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -5.72% in the last 52 weeks. The beta is 1.32, so HKG:6185's price volatility has been higher than the market average.
| Beta (5Y) | 1.32 |
| 52-Week Price Change | -5.72% |
| 50-Day Moving Average | 35.42 |
| 200-Day Moving Average | 40.89 |
| Relative Strength Index (RSI) | 48.86 |
| Average Volume (20 Days) | 647,540 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:6185 had revenue of HKD 1.19 billion and earned 31.02 million in profits. Earnings per share was 0.12.
| Revenue | 1.19B |
| Gross Profit | 1.19B |
| Operating Income | 26.61M |
| Pretax Income | 24.19M |
| Net Income | 31.02M |
| EBITDA | 232.95M |
| EBIT | 26.61M |
| Earnings Per Share (EPS) | 0.12 |
Balance Sheet
The company has 3.11 billion in cash and 1.59 billion in debt, with a net cash position of 1.52 billion or 6.15 per share.
| Cash & Cash Equivalents | 3.11B |
| Total Debt | 1.59B |
| Net Cash | 1.52B |
| Net Cash Per Share | 6.15 |
| Equity (Book Value) | 5.49B |
| Book Value Per Share | 30.05 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 100.00%, with operating and profit margins of 2.24% and 2.61%.
| Gross Margin | 100.00% |
| Operating Margin | 2.24% |
| Pretax Margin | 2.04% |
| Profit Margin | 2.61% |
| EBITDA Margin | 19.60% |
| EBIT Margin | 2.24% |
| FCF Margin | n/a |
Dividends & Yields
HKG:6185 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.32% |
| Shareholder Yield | -2.32% |
| Earnings Yield | 0.22% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |